Launch of New Accredited Online CME Module For Type 2 Diabetes

TUNBRIDGE WELLS, U.K. - Dec. 1, 2014 - PRLog -- Launch of New Accredited Online CME Module For Type 2 Diabetes

An online Continuing Medical Education (CME) activity launched today on the disease and medicines knowledge base, epgonline.org. Titled ‘The Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin', the accredited CME module has been designed to support healthcare professionals (HCPs) globally in managing patients with this serious and growing condition.

Type 2 diabetes mellitus accounts for approximately 92% of all diagnosed and undiagnosed diabetes cases, and current estimates place the number of people with diabetes in Europe at 56.3 million – 8.5% of the adult population.¹ With the age of patients at diagnosis steadily decreasing, this figure is expected to increase to 10.3% by 2035. Growing prevalence makes tackling Type 2 diabetes a key concern the world over.

HCPs globally, including endocrinologists, primary care physicians and specialist nurses, are invited to access the CME for free at http://www.epgonline.org/diabetes/type-2/cme/. It has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME), developed by a panel of leading European diabetes with support from medical communications agency Strategic Consultants and funded with an educational grand from Novo Nordisk.

Containing video, literature, case studies and interactive question and answers, the online CME activity provides a convenient source of valuable disease and management information. Educational objective focus on comorbidities and complications, as well as the complex factors that influence Type 2 Diabetes Mellitus management including the physical, emotional, social and financial aspects.

Upon successful completion of three CME modules, HCPs will be awarded 1 European credit (ECMEC) and achieve learning outcomes related to the limitations of current treatment algorithms for Type 2 Diabetes and the potential role of newer therapies to be used in combination with insulin. An independent faculty expert in the area of diabetes and endocrinology prepared each module.

Chris Cooper, Managing Director at EPG Health Media says: “Thanks to our partners in healthcare [Novo Nordisk and Strategic Consultants], users of epgonline.org can now test their comprehension of key concepts and be even better equipped to make a difference to the lives of millions of patients struggling to manage their condition.”

ENDS

For further information please contact:

Kristie Marchant (Community Manager, EPG Health Media)

Address:

Royal Victoria House

51-55 The Pantiles

Tunbridge Wells

Kent       TN2 5TE

United Kingdom

Email: kristie.marchant@epghealthmedia.com

Website: www.epghealthmedia.com

Tel: 01892 526776

Notes to Editors:

1.    EPG Health Media (Europe) Ltd publishes www.epgonline.org, an independent website dedicated to providing healthcare professionals worldwide with free access to educational resources for diseases and medicines. Content is curated from a wide variety of credible sources and includes; a database of approved medications in 9 European languages, clinical trial reports, treatment guidelines, journal abstracts, apps, latest medical industry news and a library of disease ‘Knowledge Centres’– all categorised by medical specialty.

2.    Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 38,000 employees in 75 countries, and markets its products in more than 180 countries.

3.   The faculty experts who prepared the CME modules were:

Module 1: John Wilding, the Professor of Medicine and Head of the Department of Obesity and Endocrinology at the University of Liverpool, UK.

Module 2: Richard Holt, Professor of Diabetes and Endocrinology at Southampton University, UK.

4.    Module 3: Bernard Charbonnel, Professor of Endocrinology and Metabolic Disease at the University of Nantes, France.

5.     Accreditation statement:

The 'Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin', made available on www.epgonline.org and organized by EPG Health Media (Europe) Ltd, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

The 'Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin', made available on www.epgonline.org and organized by EPG Health Media (Europe) Ltd, is awarded 1 European CME credits (ECMEC's).

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.

6.   References:

Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabetic Studies 2012;9:6-22.

International Diabetes Federation. Diabetes atlas: sixth edition. 2013. Available at: www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf (accessed 30 October 2014).